Mutations of KRAS and BRAF in Primary and Matched Metastatic Sites of Colorectal Cancer-Reference-Cited by-同舟云学术

Mutations of KRAS and BRAF in Primary and Matched Metastatic Sites of Colorectal Cancer

Published:2008-09-01 Issue:25 Volume:26 Page:4217-4219
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Artale Salvatore¹,Sartore-Bianchi Andrea¹,Veronese Silvio Marco²,Gambi Valentina¹,Sarnataro Carolina Silvia¹,Gambacorta Marcello²,Lauricella Calogero²,Siena Salvatore¹

Affiliation:

1. Falck Division of Medical Oncology, Ospedale Niguarda Ca’ Granda, Milan, Italy

2. Division of Pathology, Ospedale Niguarda Ca’ Granda, Milan, Italy

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2008.18.7286

Reference13 articles.

1. Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

2. Oncogenic Activation of the RAS/RAF Signaling Pathway Impairs the Response of Metastatic Colorectal Cancers to Anti–Epidermal Growth Factor Receptor Antibody Therapies

3. KRASMutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab

4. Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

5. Expression of Epiregulin and Amphiregulin and K-ras Mutation Status Predict Disease Control in Metastatic Colorectal Cancer Patients Treated With Cetuximab

Cited by 204 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic strategies targeting the epidermal growth factor receptor signaling pathway in metastatic colorectal cancer;World Journal of Gastrointestinal Oncology;2024-06-15

2. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-06

3. Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer;BMC Cancer;2024-01-02

4. Tumor-Free Resection Margin Distance in the Surgical Treatment of Node-Negative Squamous Cell Cancer of the Vulva Has No Impact on Survival: Analysis of a Large Patient Cohort in a Tertiary Care Center;Cancers;2023-08-15

5. Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications;Cancers;2023-08-08